Novel ergoline derivatives, compositions containing them, their preparation and use as pharmaceuticals
申请人:ELI LILLY AND COMPANY
公开号:EP0026671A1
公开(公告)日:1981-04-08
Novel D-6-n-propylergolines of the formula:
wherein Y is 0 or S and R1 is n-propyl, and pharmaceutically-acceptable acid addition salts thereof can be used to lower the prolactin level in mammals or for treating symptoms of Parkinson's syndrome in humans. A process of preparing the compounds is described which comprises reacting D-6-n-propyl-8a- mesyloxymethylergoline with the sodium salt of methylmercaptan or sodium methylate.
式中 Y 为 0 或 S,R1 为正丙基的新型 D-6-n-propylergolines 及其药学上可接受的酸加成盐可用于降低哺乳动物的催乳素水平或治疗人类帕金森综合征的症状。 所述化合物的制备过程包括将 D-6-n-propyl-8a- mesyloxymethylergoline 与甲硫醇钠盐或甲酸钠反应。